Arian Jaberi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arian Jaberi has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Amir Sheikhi
Department of Chemical Engineering The Pennsylvania State University University Park Pennsylvania USA
7 shared publications Alexander Kedzierski
Department of Biomedical Engineering The Pennsylvania State University Pennsylvania USA
3 shared publications- Roya Koshani
Department of Chemical Engineering The Pennsylvania State University University Park Pennsylvania USA
3 shared publications - Sina Kheirabadi
Department of Chemical Engineering, The Pennsylvania State University, University Park, PA 16802, USA
3 shared publications - Zaman Ataie
Department of Chemical Engineering The Pennsylvania State University University Park Pennsylvania USA
3 shared publications - Ali Tamayol
Department of Biomedical Engineering, University of Connecticut, Farmington, CT 06030, USA
1 shared publication
Latest Publications
- Open Access
- 16 November 2026
- Published by Wiley in Advanced Healthcare Materials
Microparticle‐Enabled Local Sustained Delivery of Paroxetine for Osteoarthritis Treatment
Osteoarthritis (OA) is a prevalent joint disease characterized by irreversible cartilage degradation, chronic pain, and reduced quality of life. Current treatments, including nonsteroidal anti‐inflammatory drugs (NSAIDs) and corticosteroids, are largely palliative, ineffective for some patients, and associated with adverse effects. We have shown that paroxetine (Px), an FDA‐approved antidepressant, has potential as a disease‐modifying OA drug by inhibiting the G protein‐coupled receptor kinase 2 (GRK2). Elevated GRK2 activity drives inflammation, extracellular matrix degradation and cartilage damage in OA. By inhibiting GRK2, Px suppresses cartilage degeneration, enhances chondrocyte anabolic activity, and reduces inflammation in the OA joint. In this study, we develop a local, slow‐release drug delivery system that harnesses the therapeutic benefits of Px for OA treatment via microfluidic‐assisted encapsulation in size‐controlled poly(lactic‐co‐glycolic acid) (PLGA) microparticles (MP). In vitro studies show that the drug release profile is controlled by tuning the MP fabrication parameters. Efficacy testing shows that Px‐eluting PLGA microparticles (MP‐Px) decrease fibroblast cell migration and proliferation in vitro. In vivo, the intra‐articular implantation of MP‐Px in the clinically relevant destabilization of medial meniscus mouse OA model decreases chondrocyte apoptosis and has some anti‐inflammatory effects in the acute phase of OA. Safranin O staining indicates mild staining loss in MP‐treated groups, warranting further assessment of cartilage‐matrix safety with long‐term use. Importantly, serum Px levels remain low following MP‐Px treatment compared with intraperitoneally administered Px (IP‐Px). To the best of our knowledge, this biomaterial provides the first local intra‐articular delivery of Px. These short‐term findings in mice support further preclinical evaluation of MP‐Px, including its effects on the cartilage matrix and long‐term efficacy.
- 16 November 2026
- Published by Wiley in Advanced Healthcare Materials
Open AccessMicroparticle‐Enabled Local Sustained Delivery of Paroxetine for Osteoarthritis Treatment
Osteoarthritis (OA) is a prevalent joint disease characterized by irreversible cartilage degradation, chronic pain, and reduced quality of life. Current treatments, including nonsteroidal anti‐inflammatory drugs (NSAIDs) and corticosteroids, are largely palliative, ineffective for some patients, and associated with adverse effects. We have shown that paroxetine (Px), an FDA‐approved antidepressant, has potential as a disease‐modifying OA drug by inhibiting the G protein‐coupled receptor kinase 2 (GRK2). Elevated GRK2 activity drives inflammation, extracellular matrix degradation and cartilage damage in OA. By inhibiting GRK2, Px suppresses cartilage degeneration, enhances chondrocyte anabolic activity, and reduces inflammation in the OA joint. In this study, we develop a local, slow‐release drug delivery system that harnesses the therapeutic benefits of Px for OA treatment via microfluidic‐assisted encapsulation in size‐controlled poly(lactic‐co‐glycolic acid) (PLGA) microparticles (MP). In vitro studies show that the drug release profile is controlled by tuning the MP fabrication parameters. Efficacy testing shows that Px‐eluting PLGA microparticles (MP‐Px) decrease fibroblast cell migration and proliferation in vitro. In vivo, the intra‐articular implantation of MP‐Px in the clinically relevant destabilization of medial meniscus mouse OA model decreases chondrocyte apoptosis and has some anti‐inflammatory effects in the acute phase of OA. Safranin O staining indicates mild staining loss in MP‐treated groups, warranting further assessment of cartilage‐matrix safety with long‐term use. Importantly, serum Px levels remain low following MP‐Px treatment compared with intraperitoneally administered Px (IP‐Px). To the best of our knowledge, this biomaterial provides the first local intra‐articular delivery of Px. These short‐term findings in mice support further preclinical evaluation of MP‐Px, including its effects on the cartilage matrix and long‐term efficacy.
- Open Access
- 13 November 2026
- Published by Wiley in Plant, Cell & Environment
Cell Wall Polymers Exert Distinct Effects on Mucilage Architecture and Adhesion to Help Seeds Attach to Substrates
Reforestation efforts are often constrained by low seed survival under harsh environmental conditions due to seed displacement from suitable microsites. Myxospermous seeds produce mucilage that promotes post‐dispersal attachment and water retention, thereby enhancing seed establishment. Here, we investigated the biological factors governing mechanical attachment across four myxospermous species, Ocimum basilicum (basil), Salvia hispanica (chia), Plantago ovata (psyllium), and Linum usitatissimum (flax), which occupy diverse ecological environments. We used light‐sheet fluorescence microscopy, enzymatic treatments, physical characterization methods, and functional attachment assays to investigate the mechanisms underlying mucilage‐mediated seed attachment on heterogeneous surfaces. We found variation among mucilage‐mediated seed attachments under applied hydrostatic pressure. Enzymatic treatments revealed that pectin removal causes a marked loss of adhesion across all species. However, psyllium mucilage, which possesses hemicellulosic networks, showed stronger attachment than pectin‐rich flax mucilage on rough and porous substrates. Notably, mucilage could be transplanted to non‐myxospermous seeds, conferring functional attachment capabilities. Together, our results show that species‐specific mucilage properties generate distinct modes of attachment across diverse substrates, driven by differences in polysaccharide composition and fibrillar architecture. These findings link mucilage molecular structure to seed resilience and reveal an adaptive mechanism enabling seeds to persist in heterogeneous environments.
- 13 November 2026
- Published by Wiley in Plant, Cell & Environment
Open AccessCell Wall Polymers Exert Distinct Effects on Mucilage Architecture and Adhesion to Help Seeds Attach to Substrates
Reforestation efforts are often constrained by low seed survival under harsh environmental conditions due to seed displacement from suitable microsites. Myxospermous seeds produce mucilage that promotes post‐dispersal attachment and water retention, thereby enhancing seed establishment. Here, we investigated the biological factors governing mechanical attachment across four myxospermous species, Ocimum basilicum (basil), Salvia hispanica (chia), Plantago ovata (psyllium), and Linum usitatissimum (flax), which occupy diverse ecological environments. We used light‐sheet fluorescence microscopy, enzymatic treatments, physical characterization methods, and functional attachment assays to investigate the mechanisms underlying mucilage‐mediated seed attachment on heterogeneous surfaces. We found variation among mucilage‐mediated seed attachments under applied hydrostatic pressure. Enzymatic treatments revealed that pectin removal causes a marked loss of adhesion across all species. However, psyllium mucilage, which possesses hemicellulosic networks, showed stronger attachment than pectin‐rich flax mucilage on rough and porous substrates. Notably, mucilage could be transplanted to non‐myxospermous seeds, conferring functional attachment capabilities. Together, our results show that species‐specific mucilage properties generate distinct modes of attachment across diverse substrates, driven by differences in polysaccharide composition and fibrillar architecture. These findings link mucilage molecular structure to seed resilience and reveal an adaptive mechanism enabling seeds to persist in heterogeneous environments.
- Open Access
- 28 April 2026
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 11 (3) , e70127
Orthogonally crosslinked gelatin methacryloyl microgels for in situ assembly of granular hydrogel scaffolds
Gelatin methacryloyl (GelMA) microgels formed via physical crosslinking dissolve at the physiological temperature, hindering their translational use for the in situ fabrication of granular hydrogel scaffolds (GHS). To overcome this challenge, we present a dual crosslinking strategy that combines Schiff base chemistry for GelMA microgel stabilization with subsequent free‐radical photocrosslinking to form inter‐microgel covalent bonds. This technology yields stable microgels (SμG) that may be packed and photochemically interlinked in situ to form robust granular hydrogel scaffolds (GHS SμG ) under physiological conditions. The resulting GHS SμG support high cell viability and proliferation and have pore architecture and interconnectivity, as well as mechanical properties comparable to scaffolds fabricated using physically crosslinked GelMA microgels. This work is a step forward in developing translational granular biomaterials for the in situ tissue regeneration.
- 28 April 2026
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 11 (3) , e70127
Open AccessOrthogonally crosslinked gelatin methacryloyl microgels for in situ assembly of granular hydrogel scaffolds
Gelatin methacryloyl (GelMA) microgels formed via physical crosslinking dissolve at the physiological temperature, hindering their translational use for the in situ fabrication of granular hydrogel scaffolds (GHS). To overcome this challenge, we present a dual crosslinking strategy that combines Schiff base chemistry for GelMA microgel stabilization with subsequent free‐radical photocrosslinking to form inter‐microgel covalent bonds. This technology yields stable microgels (SμG) that may be packed and photochemically interlinked in situ to form robust granular hydrogel scaffolds (GHS SμG ) under physiological conditions. The resulting GHS SμG support high cell viability and proliferation and have pore architecture and interconnectivity, as well as mechanical properties comparable to scaffolds fabricated using physically crosslinked GelMA microgels. This work is a step forward in developing translational granular biomaterials for the in situ tissue regeneration.
- 27 January 2026
- Published by Elsevier in Biomaterials
- Vol. 330, 124021
Granular aerogel scaffolds with engineered pore microarchitecture for rapid cell infiltration, tissue integration, and vascularization
- 27 January 2026
- Published by Elsevier in Biomaterials
- Vol. 330, 124021
Granular aerogel scaffolds with engineered pore microarchitecture for rapid cell infiltration, tissue integration, and vascularization
- 6 October 2025
- Published by American Chemical Society (ACS) in ACS Macro Letters
- Vol. 14 (10) , 1569-1578
Multiscale Structure–Property Relationships in Gelatin-Based Granular Hydrogel Scaffolds
Granular hydrogel scaffolds (GHS) are macroporous biomaterials composed of interlinked jammed hydrogel particles, particularly microgels. Each microgel is a crosslinked polymer network, typically with nanoscale pores. Among macromolecules, proteins such as gelatin and its derivatives are commonly used in GHS research, as their physicochemical characteristics and biological properties are well established. The hierarchical architecture of gelatin-based GHS, spanning from the nanoscale macromolecular network within microgels to jammed microgels with macroscale interstitial pores, provides modular control over the structural and functional properties of scaffolds, enabling unique biomedical applications. This Viewpoint highlights how gelatin chemistry at the molecular scale, microscale hydrogel particle design, and macroscale scaffold assembly regulate the overall behavior of gelatin-based GHS. At the molecular scale, the chemical composition of gelatin-based polymers modulates crosslinking mechanisms, degradation kinetics, and bioactivity, influencing microgel stability and mechanical behavior. At the microscale, particle size, stability, shape/porosity, and stiffness are key design factors that regulate GHS pore architecture, mechanical integrity, and cell- and tissue-biomaterial interactions, which, in turn, influence the overall properties of GHS at the macroscale. The interconnected macroporous network of GHS, tuned via microgel properties, guides cell infiltration and tissue integration, enabling applications in vascularization, immunomodulation, tissue regeneration, and 3D bioprinting. By mapping structure-property relationships from macromolecules to microgel features to scaffold properties, this Viewpoint may open new opportunities for the rational design and optimization of gelatin-based GHS for broad biomedical applications.
- 6 October 2025
- Published by American Chemical Society (ACS) in ACS Macro Letters
- Vol. 14 (10) , 1569-1578
Multiscale Structure–Property Relationships in Gelatin-Based Granular Hydrogel Scaffolds
Granular hydrogel scaffolds (GHS) are macroporous biomaterials composed of interlinked jammed hydrogel particles, particularly microgels. Each microgel is a crosslinked polymer network, typically with nanoscale pores. Among macromolecules, proteins such as gelatin and its derivatives are commonly used in GHS research, as their physicochemical characteristics and biological properties are well established. The hierarchical architecture of gelatin-based GHS, spanning from the nanoscale macromolecular network within microgels to jammed microgels with macroscale interstitial pores, provides modular control over the structural and functional properties of scaffolds, enabling unique biomedical applications. This Viewpoint highlights how gelatin chemistry at the molecular scale, microscale hydrogel particle design, and macroscale scaffold assembly regulate the overall behavior of gelatin-based GHS. At the molecular scale, the chemical composition of gelatin-based polymers modulates crosslinking mechanisms, degradation kinetics, and bioactivity, influencing microgel stability and mechanical behavior. At the microscale, particle size, stability, shape/porosity, and stiffness are key design factors that regulate GHS pore architecture, mechanical integrity, and cell- and tissue-biomaterial interactions, which, in turn, influence the overall properties of GHS at the macroscale. The interconnected macroporous network of GHS, tuned via microgel properties, guides cell infiltration and tissue integration, enabling applications in vascularization, immunomodulation, tissue regeneration, and 3D bioprinting. By mapping structure-property relationships from macromolecules to microgel features to scaffold properties, this Viewpoint may open new opportunities for the rational design and optimization of gelatin-based GHS for broad biomedical applications.
- Open Access
- 31 July 2025
- Published by Wiley in FASEB BioAdvances
- Vol. 7 (8) , e70042
A Common Mutation in the Homeostatic Iron Regulatory Gene Alters Astrocyte Migration and Redox Profile
Astrocytes play a vital role in maintaining homeostasis and function in the central nervous system, including their involvement in reparative processes. Here, we examined how a common mutation in the homeostatic iron regulatory gene, H67D HFE, impacts the antioxidant mechanism of astrocytes and migration under normal and reparative conditions. Previous data from our group suggested that this mutation may modify disease progression through an antioxidant mechanism involving nuclear factor erythroid 2‐related factor 2 (Nrf2), glutathione peroxidase 4 (GPX4), and ferritin. In this study, we used primary murine astrocytes with either the H67D or wild‐type HFE genotype to determine whether astrocytes contribute to the antioxidant protective mechanism previously observed. We analyzed their antioxidant profile and migration both at baseline and after a scratch wound injury. We found that H67D HFE astrocytes expressed the HFE protein and exhibited an enhanced antioxidant profile, marked by increased glutathione and GPX4 at baseline, and a reduced migration length into three‐dimensional granular hydrogel scaffolds. However, following scratch wound injury, these astrocytes exhibited a shift in migratory behavior, leading to faster wound infiltration. Moreover, their antioxidant response became even more pronounced after injury, with increased expression of Nrf2, GPX4, and H‐ferritin (FTH1). These results suggest that the mechanism underlying HFE mutation neuroprotection in disease processes involves an antioxidant profile in astrocytes, which is increased upon insult to activate the astrocytic reparative mechanism.
- 31 July 2025
- Published by Wiley in FASEB BioAdvances
- Vol. 7 (8) , e70042
Open AccessA Common Mutation in the Homeostatic Iron Regulatory Gene Alters Astrocyte Migration and Redox Profile
Astrocytes play a vital role in maintaining homeostasis and function in the central nervous system, including their involvement in reparative processes. Here, we examined how a common mutation in the homeostatic iron regulatory gene, H67D HFE, impacts the antioxidant mechanism of astrocytes and migration under normal and reparative conditions. Previous data from our group suggested that this mutation may modify disease progression through an antioxidant mechanism involving nuclear factor erythroid 2‐related factor 2 (Nrf2), glutathione peroxidase 4 (GPX4), and ferritin. In this study, we used primary murine astrocytes with either the H67D or wild‐type HFE genotype to determine whether astrocytes contribute to the antioxidant protective mechanism previously observed. We analyzed their antioxidant profile and migration both at baseline and after a scratch wound injury. We found that H67D HFE astrocytes expressed the HFE protein and exhibited an enhanced antioxidant profile, marked by increased glutathione and GPX4 at baseline, and a reduced migration length into three‐dimensional granular hydrogel scaffolds. However, following scratch wound injury, these astrocytes exhibited a shift in migratory behavior, leading to faster wound infiltration. Moreover, their antioxidant response became even more pronounced after injury, with increased expression of Nrf2, GPX4, and H‐ferritin (FTH1). These results suggest that the mechanism underlying HFE mutation neuroprotection in disease processes involves an antioxidant profile in astrocytes, which is increased upon insult to activate the astrocytic reparative mechanism.
- Open Access
- 15 April 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (21) , 6013-6023
Gelatin methacryloyl granular hydrogel scaffolds for skin wound healing
The pore size and structure of hydrogel scaffolds play a key role in regulating host-scaffold interactions. Incorporating macropores within bulk hydrogels may increase cell ingrowth and modulate scaffold-induced inflammation. To this end, granular hydrogel scaffolds (GHS) have been developed via assembling hydrogel microparticles (microgels). GHS have interconnected cell-scale pores, tailored by microgel size, which are readily accessible to cells. Although bulk gelatin methacryloyl (GelMA) hydrogel scaffolds have frequently been used for tissue regeneration, the efficacy of GelMA GHS in wound healing remains unknown. Here, GelMA GHS are fabricated using microfluidic-generated near-uniform microgels to study the effect of macropores on macrophage behavior in vitro, followed by assessing wound healing in a murine model of full thickness skin injury. Compared with the bulk hydrogel counterpart, macrophages interfaced with GHS secrete less interferon gamma (IFN-γ) and more insulin-like growth factor 1 (IGF-1), which show a transition to pro-healing activities. In addition, GelMA GHS improve the quality of wound healing via increasing the thickness of granulation tissue and downregulating inflammatory markers without affecting the wound closure rate. This work is a step forward in engineering GelMA scaffolds with tailored porosity for wound care.
- 15 April 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (21) , 6013-6023
Open AccessGelatin methacryloyl granular hydrogel scaffolds for skin wound healing
The pore size and structure of hydrogel scaffolds play a key role in regulating host-scaffold interactions. Incorporating macropores within bulk hydrogels may increase cell ingrowth and modulate scaffold-induced inflammation. To this end, granular hydrogel scaffolds (GHS) have been developed via assembling hydrogel microparticles (microgels). GHS have interconnected cell-scale pores, tailored by microgel size, which are readily accessible to cells. Although bulk gelatin methacryloyl (GelMA) hydrogel scaffolds have frequently been used for tissue regeneration, the efficacy of GelMA GHS in wound healing remains unknown. Here, GelMA GHS are fabricated using microfluidic-generated near-uniform microgels to study the effect of macropores on macrophage behavior in vitro, followed by assessing wound healing in a murine model of full thickness skin injury. Compared with the bulk hydrogel counterpart, macrophages interfaced with GHS secrete less interferon gamma (IFN-γ) and more insulin-like growth factor 1 (IGF-1), which show a transition to pro-healing activities. In addition, GelMA GHS improve the quality of wound healing via increasing the thickness of granulation tissue and downregulating inflammatory markers without affecting the wound closure rate. This work is a step forward in engineering GelMA scaffolds with tailored porosity for wound care.
- 10 December 2021
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 199, 113862
An equivalent circuit model for localized electroporation on porous substrates
- 10 December 2021
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 199, 113862
An equivalent circuit model for localized electroporation on porous substrates